Trials / Completed
CompletedNCT01697904
Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns
Randomized Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Preterm infants are born with immature lungs and often require help with breathing shortly after birth. This traditionally involves administering 100% oxygen. Unfortunately, delivery of high oxygen concentrations leads to the production of free radicals that can injure many organ systems. Term and near-term newborns deprived of oxygen during or prior to birth respond as well or better to resuscitation with room air (21% oxygen) compared to 100% oxygen. However, a static concentration of 21% oxygen may be inappropriate for preterm infants with lung disease.Purpose of the study is to investigate if preterm neonates where resuscitation is initiated with 21% fiO2 and adjusted to meet transitional goal saturations (Limited oxygen strategy or LOX) would have less oxidative stress as measured by the oxidative balance ratio of biological antioxidant potential/total hydroperoxide compared to infants where resuscitation is initiated with pure oxygen and titrated for targeted saturations of 85-94% (Traditional oxygen strategy or TOX). Secondary outcomes of interest included need for other delivery room resuscitation measures, respiratory support and ventilation/oxygenation status upon neonatal intensive care unit (NICU) admission, survival to hospital discharge, bronchopulmonary dysplasia and other short-term morbidities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Titration of oxygen during newborn resuscitation in delivery room |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2012-10-02
- Last updated
- 2012-10-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01697904. Inclusion in this directory is not an endorsement.